Prognostic significance of PTEN expression in esophageal squamous cell carcinoma from Linzhou City, a high incidence area of northern China

Diseases of the Esophagus

Volumn 20, Issue 6, 2007, Pages 491-496

  Chang, Dong ^a   Wang, T Y ^a   Li, H C ^b   Wei, J C ^c   Song, J X ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b XINXIANG MEDICAL UNIVERSITY   (China)

^c Esophageal Tumor Hospital of Linzhou City   (China)

Author keywords

Esophageal cancer; Immunohistochemistry; Prognosis; PTEN; Squamous cell carcinoma

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INCIDENCE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CHINA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SMALL CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR DIFFERENTIATION;

ANALYSIS OF VARIANCE; CARCINOMA, SQUAMOUS CELL; CHINA; ESOPHAGEAL NEOPLASMS; HUMANS; INCIDENCE; PROGNOSIS; PTEN PHOSPHOHYDROLASE; SURVIVAL RATE;

EID: 35448974586     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2007.00695.x     Document Type: Article

References (33)

1. Wang G Q, Abnet C C, Shen Q et al. Histological precursors of oesophageal squamous cell carcinoma: Results from a 13 year prospective follow up study in a high risk population. Gut 2005; 54: 187-92.
2. Xibib S, Meilan H, Moller H et al. Risk factors for oesophageal cancer in Linzhou, China: A case-control study. Asian Pac J Cancer Prev 2003; 4: 119-24.
3. Mandard A M, Hainaut P, Hollstein M. Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat Res 2000; 462: 335-42.
4. Kang Y H, Lee H S, Kim W H. Promoter methylation and silencing of PTEN in gastric carcinoma. Lab Invest 2002; 82: 285-91.
5. Marsit C J, Zheng S, Aldape K et al. PTEN expression in non-small-cell lung cancer: Evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration. Hum Path 2005; 36: 768-76.
6. Kondo Y, Hollingsworth E F, Kondo S. Molecular targeting for malignant gliomas. Int J Oncol 2004; 24: 1101-9.
7. Xu B, Yao Q, Dai S Z. Detection of mutation and protein expression of PTEN gene in endometrial carcinoma. Aizheng 2004; 23: 69-73.
8. Koksal I T, Dirice E, Yasar D et al. The assessment of PTEN tumor suppressor gene in combination with Gleason scoring and serum PSA to evaluate progression of prostate carcinoma. Urol Oncol 2004; 22: 307-12.
9. Zheng H C, Sun J M, Li X H, Yang X F, Zhang Y C, Xin Y. Role of PTEN and MMP-7 expression in growth, invasion, metastasis and angiogenesis of gastric carcinoma. Pathol Int 2003; 53: 659-66.
10. Goel A, Arnold C N, Niedzwiecki D et al. Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers. Cancer Res 2004; 64: 3014-21.
11. Tachibana M, Shibakita M, Ohno S et al. Expression and prognostic significance of PTEN product protein in patients with esophageal squamous cell carcinoma. Cancer 2002; 94: 1955-60.
12. An J Y, Wang L D, He X W et al. Expression of PTEN in esophageal and cardiac carcinomas from a high-incidence area in Henan province. J Zhengzhou University (Chinese) 2002; 37: 750-2.
13. Hu Y C, Lam K Y, Tang J C, Srivastava G. Mutational analysis of the PTEN/ MMAC1 gene in primary oesophageal squamous cell carcinomas. Mol Pathol 1999; 52: 353-6.
14. Ding Y, Shimada Y, Kano M et al. PTEN/MMAC1 expression in esophageal squamous cell carcinomas. Int J Oncol 2000; 17: 695-9.
15. Chang D, Li H C. Research progresses in tumor suppressor gene PTEN and esophageal carcinoma. J Xinxiang Med College (Chinese) 2005; 28: 281-4.
16. Kulke M H, Odze R D, Thakore K S et al. Allelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma. Br J Cancer 2001; 84: 748-53.
17. Greene F L, Page D L, Fleming I D et al. AJCC Cancer Staging Manual, 6th edn. New York: Springer-Verlag, 2002.
18. Sobin L H, Wittekind C. UICC TNM Classification of Malignant Tumors, 6th edn. New York: Wiley, 2002.
19. Salvesen H B, Stefansson I, Kalvenes M B, Das S, Akslen L A. Loss of PTEN expression is associated with metastatic disease in patients with endometrial carcinoma. Cancer 2002; 94: 2185-91.
20. Pallares J, Bussaglia E, Martinez-Guitarte J L et al. Immunohistochemical analysis of PTEN in endometrial carcinoma: A tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities. Mod Pathol 2005; 18: 719-27.
21. Yamada K M, Araki M. Tumor suppressor PTEN modulator of cell signaling, growth, migration and apoptosis. J Cell Sci 2001; 114: 2375-82.
22. Chu E C, Tarnawski A S. PTEN regulatory functions in tumor suppression and cell biology. Med Sci Monit 2004; 10: RA235 - -41.
23. Gimm O, Perren A, Weng L P et al. Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. Am J Pathol 2000; 156: 1693-700.
24. Chung J H, Ginn-Pease M E, Eng C. Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) has nuclear localization signal-like sequences for nuclear import mediated by major vault protein. Cancer Res 2005; 65: 4108-16.
25. Ginn-Pease M E, Eng C. Increased nuclear phosphatase and tensin homologue deleted on chromosome 10 is associated with G0-G1 in MCF-7 cells. Cancer Res 2003; 63: 282-6.
26. Chung J H, Eng C. Nuclear-cytoplasmic partitioning of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) differentially regulates the cell cycle and apoptosis. Cancer Res 2005; 65: 8096-100.
27. Im S A, Lee K E, Nam E et al. Potential prognostic significance of p185 (HER2) overexpression with loss of PTEN expression in gastric carcinomas. Tumori 2005; 91: 513-21.
28. Lee J S, Choi Y D, Lee J H et al. Expression of PTEN in the progression of cervical neoplasia and its relation to tumor behavior and angiogenesis in invasive squamous cell carcinoma. J Surg Oncol 2006; 93: 233-40.
29. Tang J M, He Q Y, Guo R X, Chang X J. Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis. Lung Cancer 2006; 51: 181-91.
30. Soria J C, Lee H Y, Lee J I et al. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation. Clin Cancer Res 2002; 8: 1178-84.
31. Frisk T, Foukakis T, Dwight T et al. Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer. Genes Chromosomes Cancer 2002; 35: 74-80.
32. Depowski P L, Rosenthal S I, Ross J S. Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer. Mod Pathol 2001; 14: 672-6.
33. Hu T H, Huang C C, Lin P R et al. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma. Cancer 2003; 97: 1929-40.